DLBCL-CI

Clinical trials for DLBCL-CI explained in plain language.

Never miss a new study

Get alerted when new DLBCL-CI trials appear

Sign up with your email to follow new studies for DLBCL-CI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy aims to boost CAR t-cell success in hard-to-treat blood cancers

Disease control Recruiting now

This early-phase study tests a radioactive drug (131-I apamistamab) given before CAR T-cell therapy for people with relapsed or hard-to-treat B-cell acute lymphoblastic leukemia or diffuse large B-cell lymphoma. The goal is to find a safe dose and see if the combination is tolera…

Matched conditions: DLBCL-CI

Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Jun 16, 2026 12:54 UTC

DLBCL-CI

Get alerted when new DLBCL-CI trials appear

New combo therapy aims to boost CAR t-cell success in hard-to-treat blood cancers